|
ZNF7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.676120E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.158590E-01 |
| Normal-vs-Stage2 |
1.820010E-01 |
| Normal-vs-Stage3 |
1.318170E-01 |
| Normal-vs-Stage4 |
1.116640E-01 |
| Stage1-vs-Stage2 |
5.133600E-01 |
| Stage1-vs-Stage3 |
5.273400E-01 |
| Stage1-vs-Stage4 |
5.922400E-01 |
| Stage2-vs-Stage3 |
9.382000E-01 |
| Stage2-vs-Stage4 |
9.829200E-01 |
| Stage3-vs-Stage4 |
9.261600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.255920E-02 |
| Normal-vs-AfricanAmerican |
1.771040E-01 |
| Normal-vs-Asian |
2.679400E-01 |
| Caucasian-vs-AfricanAmerican |
4.365600E-01 |
| Caucasian-vs-Asian |
9.533600E-01 |
| AfricanAmerican-vs-Asian |
8.304400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.872200E-02 |
| Normal-vs-Female |
1.192190E-02 |
| Male-vs-Female |
2.719200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.682100E-02 |
| Normal-vs-Extreme_Weight |
1.261030E-01 |
| Normal-vs-Obese |
1.598430E-02 |
| Normal-vs-Extreme_Obese |
3.631800E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.142200E-01 |
| Normal_Weight-vs-Obese |
7.037000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.220000E-02 |
| Extreme_Weight-vs-Obese |
3.122600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.607500E-02 |
| Obese-vs-Extreme_Obese |
6.657500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.14319999999924E-05 |
| Normal-vs-Age(41-60Yrs) |
5.296300E-03 |
| Normal-vs-Age(61-80Yrs) |
2.049400E-01 |
| Normal-vs-Age(81-100Yrs) |
8.418600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.484300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.357600E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.144200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.797800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.553400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.028200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.223700E-03 |
| Normal-VS-Type2 PRCC |
3.754800E-01 |
| Normal-VS-KIRP CIMP |
5.234300E-02 |
| Normal-VS-Unclassified PRCC |
1.088000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.54587999999789E-05 |
| Type1 PRCC-VS-KIRP CIMP |
2.545000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.519000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.218310E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.032100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.690600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.344400E-01 |
| Normal-vs-N1 |
9.918900E-03 |
| Normal-vs-N2 |
1.092780E-01 |
| N0-vs-N1 |
1.989720E-02 |
| N0-vs-N2 |
3.383000E-01 |
| N1-vs-N2 |
8.302400E-01 |
|
|
